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Protein palmitoylation involves the post-translational
attachment of palmitate in thioester linkage to cysteine
residues of proteins. The labile nature of the thioester
linkage makes possible the palmitoylation-depalmitoy-
lation cycles that have emerged in recent times as addi-
tions to the repertoire of cellular control mechanisms.
However, detailed understanding of these cycles has
been limited by the lack of knowledge of the trans-
ferases and thioesterases likely to be involved. Here, we
describe the purification of a protein-palmitoyl acyl-
transferase (PAT) from human erythrocytes. PAT be-
haved as a peripheral membrane protein and catalyzed
the attachment of palmitate in thioester linkage to the
b-subunit of spectrin. On SDS-polyacrylamide gel elec-
trophoresis, PAT appeared as a 70-kDa polypeptide. An-
tibody against this polypeptide could immunodeplete
PAT activity from the crude extract, confirming the as-
signment of the 70-kDa polypeptide as PAT. PAT-medi-
ated spectrin palmitoylation could be inhibited by non-
radioactive palmitoyl-, myristoyl-, or stearoyl-CoA. The
apparent Km for palmitoyl-CoA was 16 mM.
A large number of proteins in cells are modified by the
covalent attachment of long chain saturated fatty acid residues
(1–3). The two most common modifications involve acylation
with myristate and palmitate. Myristate is usually attached to
an N-terminal glycine via an amide bond in a relatively stable
linkage. Palmitate is usually attached via a thioester bond to
cysteine residues of proteins. Palmitoylation occurs in mem-
brane proteins with hydrophobic transmembrane segments as
well as in hydrophilic proteins such as Ras (1–4). These lipid
modifications have often been implicated in membrane associ-
ation of the modified proteins (5). Palmitoylation occurs post-
translationally. Moreover, rapid turnover of the protein-bound
fatty acid has been shown for several proteins (6–8). The
recent surge of interest in studying protein palmitoylation is
largely due to the fact that a number of proteins involved in
intracellular signaling are palmitoylated, and this appears to
be regulated by the activation status of these proteins (9–12).
Palmitoylation occurs in, among others, the families of (i) G
protein-linked receptors, (ii) the subunits of heterotrimeric G
proteins, and (iii) the non-receptor tyrosine kinases. Palmitate
plays a role in the membrane association of these polypeptides.
Moreover, recent evidence suggests that this may regulate
protein-protein interactions such as those between growth
cone-associated protein 43 and Goa in neurons (13). Although
evidence that the interactions of G proteins with effectors are
regulated by palmitoylation is becoming compelling, very little
is known about the enzymes involved in the catalysis of the
palmitoylation and depalmitoylation of these or other proteins.
A clear understanding of the palmitoylation-depalmitoyla-
tion cycle as a cellular control mechanism obviously entails
characterization of the protein palmitoyltransferase(s) and
thioesterase(s). A thioesterase has recently been purified (14),
and a corresponding cDNA has been cloned (15). However,
since this thioesterase is a secreted protein, whereas Ras and
Ga subunits are located on the cytoplasmic layer of the plasma
membrane, these proteins may not be its physiologic sub-
strates. The protein-palmitoyl acyltransferase (PAT)1 has re-
mained, until lately, refractory to purification. PAT activity has
been demonstrated in several eukaryotic membranes (16–20)
and partially purified from bovine brain (21) and from rat liver
(22).
In our laboratory and that of others, palmitate associated
with erythrocyte membrane cytoskeletal proteins has been
demonstrated to undergo turnover (23), and palmitoylation has
been found to modulate association of erythrocyte protein 4.2
with the membrane (24). These findings necessitated under-
standing the role of palmitoylation-depalmitoylation cycles in
modulating interactions among erythrocyte cytoskeletal pro-
teins, and efforts were made to characterize the PAT from
human erythrocytes. This study reports the purification and
biochemical characterization of a protein-palmitoyl acyltrans-
ferase from human erythrocytes.
MATERIALS AND METHODS
Reagents—[14C]Palmitoyl-CoA and [9,10-3H]palmitic acid were from
Amersham International (Buckinghamshire, United Kingdom). Aproti-
nin, leupeptin, pepstatin, benzamidine, phenylmethylsulfonyl fluoride,
dithiothreitol, nonradioactive fatty acyl-CoAs, and Formalin-fixed
Staphylococcus aureus bearing protein A were from Sigma. Staphylo-
coccal V8 protease was from Pierce. All other reagents were of analyt-
ical grade.
Purification of PAT—Fresh blood was collected from normal healthy
volunteers and washed in phosphate-buffered saline, and erythrocytes
were packed and lysed in lysis buffer (7.5 mM sodium phosphate, 1 mM
Na2EDTA, pH 7.5, containing 30 mg/ml aprotinin, 1 mg/ml leupeptin, 1
mg/ml pepstatin, 10 mg/ml benzamidine, and 20 mg/ml phenylmethyl-
sulfonyl fluoride). Ghosts were pelleted, washed, and extracted with 10
volumes of 0.2 mM Na2EDTA, pH 7.5 (i.e. low ionic strength extraction
buffer), containing 20 mg/ml phenylmethylsulfonyl fluoride at 37 °C for
30 min. After centrifugation at 19,000 rpm (SS-34) for 30 min, the pellet
was further extracted with an equal volume of KCl extraction buffer
(7.5 mM sodium phosphate, 1 mM Na2EDTA, 1 mM dithiothreitol, 1 M
KCl, pH 7.5) on ice for 30 min. After centrifugation at 20,000 rpm
(SS-34) for 30 min, the supernatant (KCl extract) was dialyzed exten-
sively against 20 mM piperazine buffer, pH 9.5. The dialysate was
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loaded on a Mono Q HR5/5 column (Pharmacia Biotech Inc.) equili-
brated against the same buffer and fitted to a Pharmacia FPLC system.
After washing the column, proteins were eluted with an increasing salt
gradient (0–1 M NaCl). Fractions were assayed for PAT activity by the
immunoprecipitation technique and analyzed by SDS-PAGE. Fractions
that appeared homogeneous on SDS-PAGE and showed PAT activity
were pooled, neutralized, and processed further.
Fast Desalting Chromatography—Mono Q fractions containing PAT
activity were chromatographed on a Pharmacia Fast desalting column
(HR10/10) equilibrated in 100 mM imidazole buffer, pH 7.5, to bring the
purified PAT in this buffer. Fractions were finally stored at 270 °C.
Under these conditions, the enzyme gradually lost activity over a period
of 2 weeks.
Purification of Spectrin—Spectrin was purified as described by Ben-
nett (25), stored at 270 °C, and used within 2 weeks.
Raising of Antibodies against PAT and against Spectrin—Purified
PAT or spectrin (75 mg) was injected subcutaneously with complete
Freund’s adjuvant into one male rabbit each. Successive injections of 40
mg each with incomplete Freund’s adjuvant were given at the end of the
2nd, 3rd, and 4th weeks, followed by bleeding at the end of the 5th
week.
SDS-PAGE—SDS-PAGE was performed using the discontinuous
buffer system of Laemmli (26). Samples were dissolved in 62.5 mM
Tris-HCl containing 2% (w/v) SDS, 10% (v/v) glycerol, 1% (v/v) 2-mer-
captoethanol, and 0.01% bromphenol blue. Gels were impregnated with
2,5-diphenyloxazole for autoradiography as described by Laskey and
Mills (27).
PAT Assay and Analysis by Fluorography—Routinely, spectrin was
incubated with PAT and [14C]palmitoyl-CoA in 100 mM imidazole
buffer, pH 7.5, at 37 °C as described in the figure legends. Following
reaction, samples were boiled in denaturing SDS gel buffer and sepa-
rated on 7.5% SDS gels, followed by fluorography. To study the nature
of PAT-mediated palmitoylation of spectrin, gels containing 14C-palmi-
toylated spectrin were treated (a) with CHCl3/CH3OH or (b) with 1 M
neutral hydroxylamine prior to fluorography. Competition with nonra-
dioactive octanoyl-, decanoyl-, lauroyl-, myristoyl-, palmitoyl-, and ste-
aroyl-CoAs was performed by assaying PAT activity using 40 mM
[14C]palmitoyl-CoA and a 2-fold excess of nonradioactive acyl-CoA as
described above.
PAT Assay by Immunoprecipitation of Spectrin—PAT assay was
carried out using 8 mg of spectrin and 40 mM [14C]palmitoyl-CoA (50
mCi/mmol) in 100 mM imidazole buffer, pH 7.5, in a final volume of 30
ml. Incubations were usually carried out for 40 min at 37 °C unless
otherwise stated. Following reaction, 20 ml of anti-spectrin antibody
was added in a final volume of 100 ml containing 120 mM KCl, 5 mM
sodium phosphate, pH 8, 0.5 mM EGTA, 0.5 mM dithiothreitol, 0.1%
Triton X-100, and 1 mg/ml gelatin and incubated for 30 min at 25 °C.
The amount of antibody and the time of incubation were found to be
adequate for immunoprecipitating spectrin in all the assays reported
here. This was followed by the addition of 100 ml of 10% Formalin-fixed
S. aureus bearing protein A (washed with Buffer A (120 mM KCl, 5 mM
sodium phosphate, pH 8, 0.5 mM EGTA, 0.5 mM dithiothreitol, 1 mM
EDTA, 0.1% Triton X-100, 1 mg/ml gelatin)) and a further incubation
for 1 h at 25 °C.
The S. aureus protein A with the bound antigen-antibody complex
was sedimented at 10,000 3 g for 3 min in a microcentrifuge and
washed three times with 1-ml aliquots of Buffer A. The pellet with
bound spectrin was counted in a liquid scintillation counter. For each
experiment, a control sample lacking PAT was prepared and treated
exactly as described above to correct for any nonspecific acylation of
spectrin and any adherence of [14C]palmitoyl-CoA to the S. aureus
protein A beads. The counts associated with the beads in these control
tubes were subtracted from the counts of the corresponding PAT-con-
taining tubes. The control values did not exceed 10–15% of those ob-
tained in the presence of PAT. The stoichiometry of spectrin palmitoy-
lation was determined using varying amounts of spectrin (2–6 mg), 40
mM [14C]palmitoyl-CoA, and 10 mg/ml PAT. The reaction was allowed to
proceed for 60 min, followed by immunoprecipitation of spectrin as
described above.
Immunoprecipitation of PAT—This was performed essentially as
described by Firestone and Winguth (28). Fresh KCl extract (25 mg) was
incubated with various amounts of rabbit anti-PAT IgG or preimmune
IgG in 30 ml for 1 h on ice in plastic tubes. Then 10 ml of a 10%
suspension of prewashed S. aureus protein A was added and incubated
for 1 h on ice with occasional shaking. The tubes were centrifuged, and
the supernatants (15 ml) were assayed for PAT activity.
Analysis of the Spectrin-bound Labeled Fatty Acid—14C-Palmitoy-
lated spectrin was excised from SDS gels. The gel slices were incubated
with 1 ml of 1.5 N NaOH at 30 °C for 3 h. The pH was then adjusted to
1–2 with 6 M HCl. The hydrolysate was extracted with CHCl3/CH3OH,
and the organic phase was dried under nitrogen. The extracted lipid
was analyzed by ascending chromatography on a reverse-phase C18
TLC plate using acetonitrile/acetic acid (1:1, v/v) as the mobile phase.
[3H]Palmitic acid and [3H]myristic acid were used as standards. The
plate was scraped, and the radioactivity was determined in parts to
determine the relative migration of radiolabeled species in the samples.
Labeling of Erythrocytes with [3H]Palmitic Acid and Extraction of
Labeled Spectrin—Human erythrocytes were labeled with [3H]palmitic
acid, and tightly membrane-associated spectrin was extracted as de-
FIG. 1. Palmitoylation of spectrin catalyzed by the 1 M KCl
extract from human erythrocytes. Spectrin (100 mg/ml) was incu-
bated in a volume of 20 ml for 40 min at 37 °C with 40 mM [14C]palmitoyl-
CoA (50 mCi/mmol) in imidazole buffer without the KCl extract (lane 1),
with the KCl extract (150 mg/ml) (lane 2), or with the KCl extract after
it had been boiled for 5 min at 100 °C (lane 3), followed by SDS-PAGE
and fluorography (exposure time: 15 days).
FIG. 2. Purification of erythrocyte PAT. A, chromatographic elu-
tion profile of PAT activity on Mono Q HR5/5 at pH 9.5. PAT activity
(pmol of [14C]palmitoyl-CoA transferred per min/ml of fraction) was
assayed by immunoprecipitation of spectrin as described under “Mate-
rials and Methods.” Assays were performed using 15 ml of the Mono Q
fractions after neutralization. B, SDS-PAGE analysis of proteins pres-
ent in fractions 41 (lane a), 43 (lane b), 45 (lane c), and 47 (lane d) of the
Mono Q column. 100 ml of each fraction was freeze-dried and loaded on
the gel. PAT activity has been assigned to the 70-kDa protein (indicated
by the arrow). C, sequentially purified fractions of erythrocyte ghosts
after Coomassie Brilliant Blue staining. Lane 1, erythrocyte ghost; lane
2, KCl extract; lane 3, purified PAT after chromatography on Mono Q
(fraction 45, 1 mg)
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scribed by Mariani et al. (4) with slight modifications. After washing the
cells three times with phosphate-buffered saline/glucose (10 mM phos-
phate, 140 mM NaCl, 5 mM KCl, 0.5 mM EDTA, 5 mM glucose, pH 7.4),
the cells were incubated twice for 15 min at room temperature with 10
volumes of Buffer B (40 mM imidazole, 90 mM NaCl, 5 mM KCl, 5 mM
MgCl2, 15 mM glucose, 0.5 mM EGTA, 30 mM sucrose, 0.3 mM phenyl-
methylsulfonyl fluoride, 200 units of penicillin G, pH 7.6) containing
0.2% fatty acid-free bovine serum albumin to lower the endogenous pool
of fatty acids. The bovine serum albumin-treated cells were washed
once with Buffer B containing 5 mM coenzyme A and 5 mM pyruvate
(Buffer C). Packed erythrocytes (2 ml) were labeled with 0.5 mCi of
[9,10-3H]palmitic acid (54 Ci/mmol) at a hematocrit of 0.3 in Buffer C
for 12 h at 37 °C. The labeling was stopped by adding cold phosphate-
buffered saline/glucose and washing twice with the same buffer con-
taining 0.2% fatty acid-free bovine serum albumin. Membranes were
prepared by hypotonic lysis as described above. KCl-stripped inside-out
vesicles were prepared as described by Mariani et al. (4), and tightly
membrane-associated spectrin was extracted in the presence of 5 M urea
(4) and concentrated with a Millipore Ultrafree microcentrifuge filter
(Mr 100,000 cutoff) to 1–2 mg/ml.
Peptide Analyses of Spectrin—The method of Cleveland et al. (29)
was followed. Tightly membrane-associated spectrin (representing the
in vivo palmitoylated form of spectrin) as well as spectrin palmitoylated
in vitro using PAT were electrophoretically separated on a 5% SDS gel.
Gel pieces containing the b-subunit of spectrin were excised, rehydrated
in Buffer D (0.125 M Tris-HCl, pH 6.8, 0.1% SDS, 1 mM EDTA), and
placed in the sample well of a second SDS gel (15% acrylamide). The
spaces of the wells were filled with Buffer D containing 20% glycerol
and S. aureus V8 protease (at an enzyme/substrate ratio of 1:2). Diges-
tion was allowed to proceed in the stacking gel for 30 min. Electrophore-
sis was then continued, and the gel was treated for fluorography.
RESULTS
Purification of PAT from Human Erythrocytes and Use of
Spectrin as a Substrate of PAT—Human erythrocyte ghosts
have previously been shown to have PAT activity (20). In this
study, ghosts were subjected to sequential extraction with buff-
ers of increasing ionic strength. PAT activity was assessed by
studying the palmitoylation of spectrin. After extraction with
low ionic strength extraction buffer, PAT activity remained
associated with the membrane vesicles, and no activity was
detectable in the supernatant. PAT activity could be extracted
in buffer containing 1 M KCl. The 1 M KCl extract catalyzed the
palmitoylation of predominantly the b-subunit of spectrin (Fig.
1). This extract was dialyzed against 20 mM piperazine buffer,
pH 9.5, and fractionated on a Mono Q column as described
under “Materials and Methods.” PAT activity was associated
with a 70-kDa polypeptide that eluted between 0.7 and 0.9 M
NaCl (Fig. 2). Active fractions that appeared homogeneous on
SDS-PAGE and showed an activity $80 pmol/min/ml were
neutralized, chromatographed on a Pharmacia Fast desalting
column, and brought to 100 mM imidazole buffer, pH 7.5. The
purification is summarized in Table I. Both erythrocyte ghosts
and vesicles remaining after low ionic strength extraction were
sources of PAT as assessed by fluorography using spectrin as
substrate. However, these could not be included in the purifi-
cation table. Quantitative measurements of PAT activity could
not be made with ghosts or vesicles remaining after low ionic
strength extraction since this would necessitate solubilization
of the PAT from the membranes. However, we and others (20)
have observed that detergents such as Triton X-100 used at
concentrations usually necessary for solubilization of mem-
brane proteins ('1%) were inhibitory for PAT activity. Besides
this, ghosts contained substantial amounts of spectrin, the
substrate used in these studies to assess PAT activity. There-
fore, this was an additional impediment in the quantitation of
PAT activity. PAT obtained after Fast desalting chromatogra-
phy was purified 86-fold over the KCl extract. However, an
assessment of the -fold purification over the ghosts could not be
made for the reasons stated above.
The assignment of the 70-kDa protein as PAT was confirmed
by immunoprecipitation using antibody raised against this pro-
tein. This antibody precipitated PAT activity from the KCl
extract in a dose-dependent manner (Fig. 3), while preimmune
IgG showed no such effect.
The PAT-catalyzed incorporation of radioactivity into spec-
trin from [14C]palmitoyl-CoA was studied as a function of time.
PAT palmitoylated spectrin in a time-dependent manner (Fig.
4A), reaching a plateau after 40 min of incubation. Palmitoy-
lation of spectrin increased with increasing amounts of the
enzyme (Fig. 5), confirming that the transfer of the palmitoyl
moiety to spectrin is an enzymatic process. PAT activity in the
KCl extract was abolished on heating the enzyme for 5 min at
100 °C (Fig. 1, lane 3). The apparent Km for palmitoyl-CoA was
found to be 16 mM (Fig. 4B). It was observed that the inhibition
of PAT activity by nonradioactive fatty acyl-CoAs was depend-
ent on the chain length of the fatty acyl-CoAs. Octanoyl-, dec-
anoyl-, and lauroyl-CoAs were poor inhibitors of PAT activity
(,10% inhibition). Among the longer chain fatty acyl-CoAs,
when used in 2-fold excess over radioactive palmitoyl-CoA, the
ability to compete with [14C]palmitoyl-CoA was as follows:
palmitoyl-CoA . myristoyl-CoA . stearoyl-CoA (Fig. 6A). In
this connection, it may be mentioned that myristate has been
demonstrated to be present in thioester linkage in platelet
proteins (30).
Palmitoylation of Spectrin Occurs via a Thioester Linkage—
The chemical nature of PAT-mediated spectrin palmitoylation
was investigated by soaking the polyacrylamide gel containing
palmitoylated spectrin in CHCl3/CH3OH (Fig. 6B) or in neutral
hydroxylamine. While soaking the gel in CHCl3/CH3OH had no
effect, the bound radioactive palmitate could be removed by
treatment with neutral hydroxylamine (Fig. 6B), confirming
FIG. 3. Immunoprecipitation of PAT activity from the KCl ex-
tract. The KCl extract was incubated with varying amounts of preim-
mune (E) or immune (l) IgG, and the antigen-antibody complexes were
precipitated. PAT activity was quantitated in the supernatants by
spectrin immunoprecipitation as described under “Materials and
Methods.”
TABLE I
Summary of purification of erythrocyte PAT
Step Protein Activity Specific activity Purification Yield
mg pmol CoA/min pmol CoA/min/mg -fold %
KCl extract 14 840 60 100
Mono Q chromatography 0.08 330 4700 78 39
Fast desalting chromatography 0.06 300 5200 86 36
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that palmitoylation of spectrin occurs via a thioester linkage.
In a parallel experiment, palmitoylated spectrin was excised
from the gel and hydrolyzed. The hydrolysate was extracted
with organic solvents and analyzed by TLC. The RF value of the
sample was identical to that of standard radioactive palmitic
acid, identifying the fatty acid incorporated into spectrin as
palmitic acid (Fig. 6C). The stoichiometry of palmitoylation was
determined by immunoprecipitation of spectrin after labeling
with [14C]palmitoyl-CoA. Incorporation of the palmitoyl moiety
into spectrin occurred in a 1:1 molar ratio of fatty acid to
spectrin (a 1 b) (data not shown).
Cleveland Mapping of in Vitro and in Vivo Palmitoylated
b-Spectrin—To investigate whether the fatty acid bound to
spectrin palmitoylated in vitro using PAT is incorporated in the
same site(s) as in vivo, peptide maps of in vivo and in vitro
labeled spectrin (b-subunit) were compared using the Cleve-
land V8 protease digestion technique of gel slices, followed by
fluorography (as described under “Materials and Methods”).
The V8 protease digestion gave one major palmitoylated pep-
tide in the second dimension SDS-PAGE after fluorography.
This was present in the case of both the in vivo and in vitro
labeled spectrin (migrating with an apparent molecular mass
of 45 kDa) (Fig. 7), suggesting that the same site is labeled on
the protein in both cases.
DISCUSSION
Our understanding of dynamic protein palmitoylation as a
cellular control mechanism has been limited by the lack of
detailed knowledge about the enzymology of palmitoylation
and the fact that no PAT has been isolated to date. Progress
toward the purification of PAT has been hampered by the lack
of a rapid and sensitive method of assay, by the absence of an
apparent consensus sequence at sites of palmitoylation, and by
the relative instability of the enzymes identified so far. Our
search for the PAT from human erythrocytes was based on our
own observations and that of other laboratories that protein-
bound palmitate associated with erythrocyte membrane pro-
teins turns over (8, 23). Moreover, palmitoylating activity has
FIG. 4. In vitro assay of erythrocyte PAT activity. A, the effect of
varying incubation time on PAT activity. PAT activity was assessed
using the immunoprecipitation technique described under “Materials
and Methods.” Assays were performed using 64 mg of spectrin, 40 mM
[14C]palmitoyl-CoA (50 mCi/mmol), and 1.2 mg of enzyme in a final
volume of 200 ml. Aliquots of 25 ml were withdrawn at different time
points and heated at 100 °C for 5 min in order to inactivate PAT.
Immunoprecipitation of spectrin was performed as described under
“Materials and Methods.” B, determination of the Km for [
14C]palmitoyl-
CoA. Spectrin (8 mg) was incubated with increasing concentrations of
[14C]palmitoyl-CoA (50 mCi/mmol) at 37 °C and 0.15 mg of PAT in 25 ml.
PAT activity was quantified by immunoprecipitation of spectrin, and
the Km was determined from the Lineweaver-Burk plot. The results
shown represent the means 6 S.D. from three different experiments.
FIG. 5. Effect of increasing concentrations of erythrocyte PAT
on spectrin palmitoylation. PAT activity was assessed by fluorogra-
phy as described under “Materials and Methods.” Assays were per-
formed using 2 mg of spectrin and 40 mM [14C]palmitoyl-CoA. Lanes 1–4
represent assays performed using 1, 2, 3, and 6 mg/ml PAT, respectively.
FIG. 6. Fatty acyl-CoA specificity of spectrin palmitoylation. A,
spectrin was acylated using 40 mM [14C]palmitoyl-CoA in the absence
(lane a) and presence (80 mM) of nonradioactive lauroyl-CoA (lane b),
stearoyl-CoA (lane c), myristoyl-CoA (lane d), and palmitoyl-CoA (lane
e). B, gels of palmitoylated spectrin were treated with 1 M Tris-HCl, pH
7.5 (lane 1); CHCl3/CH3OH (7:3, v/v) (lane 2); and 1 M neutral hydrox-
ylamine (lane 3) for 4 h. C, radioactivity released after hydrolysis of
palmitoylated spectrin was analyzed by reverse-phase TLC with
[3H]palmitic acid as a standard. After ascending chromatography, sam-
ples 1 cm in height and 2 cm in width were scraped from the plate, and
radioactivity was determined. E, standard [3H]palmitic acid; l, radio-
active fatty acid released from palmitoylated spectrin.
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recently been demonstrated in human erythrocyte ghosts (20).
Our choice of spectrin as substrate was based on the observa-
tions of Mariani et al. (4) that a tightly membrane-associated
fraction of spectrin is palmitoylated when human erythrocytes
are metabolically labeled with [3H]palmitic acid. Spectrin is an
abundant cytoskeletal protein of the erythrocyte that can be
easily purified in substantial quantities. In the absence of
knowledge on the defined substrate requirement of erythrocyte
PAT, spectrin appeared to be a feasible alternative to a peptide
substrate that could be used for monitoring the purification of
PAT. PAT activity could be extracted from erythrocyte ghosts
in buffer containing 1 M KCl. Erythrocyte PAT therefore ap-
peared to behave like a peripheral membrane protein, unlike
the PAT identified in bovine brain (21). On the other hand, the
rat liver palmitoyltransferase is solubilized from membranes
using 150 mM KCl, suggesting that this enzyme, like erythro-
cyte PAT, may not be tightly bound to membranes. The in-
crease in specific activity of purified PAT in comparison with
the KCl extract was 86-fold. PAT was extremely labile and
susceptible to proteolysis, as reported earlier by others (21). A
67-kDa band reactive with anti-PAT antibody appeared below
the 70-kDa polypeptide in the KCl extract on storage (data not
shown). To avoid proteolysis, the purification steps were per-
formed as quickly as possible.
Purified PAT appeared as a 70-kDa polypeptide on SDS-
PAGE. The identity of this polypeptide as PAT was confirmed
by immunodepletion of PAT activity using antibody against the
70-kDa polypeptide. Nonradioactive palmitoyl-, myristoyl-, and
stearoyl-CoAs were competitors of [14C]palmitoyl-CoA, a fea-
ture also observed in the case of bovine brain PAT (21).
Dynamic protein palmitoylation represents a recent addition
to the repertoire of cellular control mechanisms. Understand-
ing the control of palmitoylation-depalmitoylation cycles neces-
sitates characterization of the enzymes involved in these pro-
cesses. Purification of the PAT from human erythrocyte
membranes has opened up exciting avenues. Whether the
plasma membrane-associated PAT from erythrocytes is identi-
cal to or different from PAT activities associated with other
membranes (21, 22) needs to be evaluated. Dissection of the
palmitoylation site of spectrin will provide necessary knowl-
edge of the likely substrate requirements of the PAT purified
here. Partially purified bovine brain PAT recognizes the N-
terminal “myristoyl-Gly-Cys” sequence of the Src family pro-
tein-tyrosine kinases like Fyn (21), while rat liver PAT recog-
nizes a farnesylated and methylated Ha-Ras peptide. Since
spectrin lacks these motifs, erythrocyte PAT is likely to repre-
sent one of a family of palmitoyltransferases of different sub-
strate specificity and probably of different subcellular
localization.
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FIG. 7. Peptide mapping after in vitro and in vivo palmitoyla-
tion of spectrin. Spectrin was labeled with [14C]palmitoyl-CoA and
PAT (for in vitro acylation) as described under “Materials and Meth-
ods.” In vivo acylation was carried out on erythrocytes using radioactive
palmitic acid as described under “Materials and Methods.” Tightly
membrane-associated spectrin labeled in vivo or spectrin labeled in
vitro was electrophoresed on a 5% SDS gel, and the bands correspond-
ing to the b-subunit were excised (5 mg of protein) and subjected to V8
protease digestion during the second dimension electrophoresis on a
15% SDS gel. The gels were treated for fluorography. Lane a, in vitro
acylation; lane b, in vivo acylation. The position of the major palmitoy-
lated peptide is indicated with an arrow.
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